UniProt ID | CD5R1_HUMAN | |
---|---|---|
UniProt AC | Q15078 | |
Protein Name | Cyclin-dependent kinase 5 activator 1 | |
Gene Name | CDK5R1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 307 | |
Subcellular Localization |
Cyclin-dependent kinase 5 activator 1, p35: Cell membrane Lipid-anchor Cytoplasmic side . In the primary cortical neurons, p35 is present in the peripheries and nerve terminals. Cyclin-dependent kinase 5 activator 1, p25: Nucleus. Cytoplasm, per |
|
Protein Description | p35 is a neuron specific activator of CDK5. The complex p35/CDK5 is required for neurite outgrowth and cortical lamination. Involved in dendritic spine morphogenesis by mediating the EFNA1-EPHA4 signaling. Activator of TPKII. The complex p35/CDK5 participates in the regulation of the circadian clock by modulating the function of CLOCK protein: phosphorylates CLOCK at 'Thr-451' and 'Thr-461' and regulates the transcriptional activity of the CLOCK-ARNTL/BMAL1 heterodimer in association with altered stability and subcellular distribution.. | |
Protein Sequence | MGTVLSLSPSYRKATLFEDGAATVGHYTAVQNSKNAKDKNLKRHSIISVLPWKRIVAVSAKKKNSKKVQPNSSYQNNITHLNNENLKKSLSCANLSTFAQPPPAQPPAPPASQLSGSQTGGSSSVKKAPHPAVTSAGTPKRVIVQASTSELLRCLGEFLCRRCYRLKHLSPTDPVLWLRSVDRSLLLQGWQDQGFITPANVVFLYMLCRDVISSEVGSDHELQAVLLTCLYLSYSYMGNEISYPLKPFLVESCKEAFWDRCLSVINLMSSKMLQINADPHYFTQVFSDLKNESGQEDKKRLLLGLDR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | N-myristoyl glycine | ------MGTVLSLSP ------CCCEEECCH | 25.24 | - | |
2 | Myristoylation | ------MGTVLSLSP ------CCCEEECCH | 25.24 | 20213681 | |
3 | Phosphorylation | -----MGTVLSLSPS -----CCCEEECCHH | 19.58 | 29759185 | |
6 | Phosphorylation | --MGTVLSLSPSYRK --CCCEEECCHHHCC | 23.59 | 29759185 | |
8 | Phosphorylation | MGTVLSLSPSYRKAT CCCEEECCHHHCCEE | 14.39 | 17121855 | |
10 | Phosphorylation | TVLSLSPSYRKATLF CEEECCHHHCCEEEE | 33.91 | 29759185 | |
91 | Phosphorylation | ENLKKSLSCANLSTF CHHHHHHCCCCHHHC | 20.48 | 20097924 | |
134 | Phosphorylation | KAPHPAVTSAGTPKR CCCCCCCCCCCCCCE | 18.24 | 27732954 | |
135 | Phosphorylation | APHPAVTSAGTPKRV CCCCCCCCCCCCCEE | 20.36 | 27732954 | |
138 | Phosphorylation | PAVTSAGTPKRVIVQ CCCCCCCCCCEEEEE | 25.92 | 18507738 | |
234 | Phosphorylation | LTCLYLSYSYMGNEI HHHHHHHHHHCCCCC | 10.96 | - | |
263 | Phosphorylation | AFWDRCLSVINLMSS HHHHHHHHHHHHHHC | 25.28 | 29759185 | |
269 | Phosphorylation | LSVINLMSSKMLQIN HHHHHHHHCCCCCCC | 29.94 | 29759185 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
8 | S | Phosphorylation | Kinase | CDK5 | Q00535 | Uniprot |
8 | S | Phosphorylation | Kinase | CDK5 | P49615 | PSP |
91 | S | Phosphorylation | Kinase | SIK2 | Q9H0K1 | GPS |
138 | T | Phosphorylation | Kinase | CDK5 | Q00535 | Uniprot |
138 | T | Phosphorylation | Kinase | CDK5 | P49615 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CD5R1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Myristoylation | |
Reference | PubMed |
"Strategy for comprehensive identification of human N-myristoylatedproteins using an insect cell-free protein synthesis system."; Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,Tsunasawa S., Utsumi T.; Proteomics 10:1780-1793(2010). Cited for: MYRISTOYLATION AT GLY-2. | |
"Myristoylation of p39 and p35 is a determinant of cytoplasmic ornuclear localization of active cyclin-dependent kinase 5 complexes."; Asada A., Yamamoto N., Gohda M., Saito T., Hayashi N., Hisanaga S.; J. Neurochem. 106:1325-1336(2008). Cited for: SUBCELLULAR LOCATION, MYRISTOYLATION, AND MUTAGENESIS OF GLY-2. | |
Phosphorylation | |
Reference | PubMed |
"Suppression of calpain-dependent cleavage of the CDK5 activator p35to p25 by site-specific phosphorylation."; Kamei H., Saito T., Ozawa M., Fujita Y., Asada A., Bibb J.A.,Saido T.C., Sorimachi H., Hisanaga S.; J. Biol. Chem. 282:1687-1694(2007). Cited for: PHOSPHORYLATION AT SER-8 AND THR-138, AND MUTAGENESIS OF SER-8 ANDTHR-138. |